Hyperimmune intravenous immunoglobulin doesn't help COVID-19 patients: Study
The combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treating adults hospitalised with COVID-19, according to recent research.